Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

Author:

Kahn René S,Winter van Rossum Inge,Leucht Stefan,McGuire Philip,Lewis Shon W,Leboyer Marion,Arango Celso,Dazzan Paola,Drake Richard,Heres Stephan,Díaz-Caneja Covadonga M,Rujescu Dan,Weiser Mark,Galderisi Silvana,Glenthøj Birte,Eijkemans Marinus J C,Fleischhacker W Wolfgang,Kapur Shitij,Sommer Iris E,Kahn René S,Sommer Iris E,Winter-van Rossum Inge,Somers Metten,Ywema Paula C,Kapur Shitisj,McGuire Philip,Leboyer Marion,Meyer-Lindenberg Andreas,Lewis Shon W,Leucht Stefan,Arango Celso,Fleischhacker Wolfgang W,Meijering Anne Lotte,Petter Jocelyn,Van de Brug Resy,Schotsman Joost,Zwerver Jildou,Peuskens Jos,De Hert Marc,Thys Erik,Hranov Lucho G,Hranov Valentin,Libiger Jan,Köhler Richard,Mohr Pavel,Glenthoj Birte,Broberg Brian,Düring Signe,Baandrup Lone,Jamain Stephane,Heres Stephan,Rujescu Dan,Giegling Ina,Weiser Mark,Bar Heim Mor,Davidson Michael,Galderisi Silvana,Bucci Paola,Mucci Armida,Rybakowski Janusz,Remlinger-Molenda Agnieszka,Gonen Ilan,Radu Paull,Díaz-Marsá Marina,Rodriguez Alberto,Palomo Tomas,Rodriguez-Jimenez Roberto,García-Portilla Paz,Bernardo Miquel,Bobes Julio,Vilares Oliveira Christina,Berger Gregor,Wildt Claudia,Dazzan Paola,Perez-Iglesias Roccio,Drake Richard,Gregory Sarah,Wilson Danielle,Díaz-Caneja Covadonga M,Eijkemans Marinus J C

Funder

European Commission Seventh Framework Program

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference25 articles.

1. Remission in schizophrenia: proposed criteria and rationale for consensus;Andreasen;Am J Psychiatry,2005

2. Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment;Lambert;Eur Psychiatry,2010

3. On the concept of remission in schizophrenia;Leucht;Psychopharmacology,2007

4. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial;Kahn;Lancet,2008

5. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity;Schoemaker;J Pharmacol Exp Ther,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3